gsk3923868
Showing 1 - 3 of 3
Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- GSK3923868
- Placebo
- (no location specified)
Jan 9, 2023
Pulmonary Disease, Chronic Obstructive Trial in Cambridge (GSK3923868, Matching , Monodose RS01)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK3923868
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Sep 26, 2022
Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- GSK3923868
- Placebo
- (no location specified)
May 26, 2022